Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Divi Cornec

Showing results (181-190 of 197) with videos related to

Pageof 20
Sort By:
Annals of the Rheumatic Diseases|December 25, 2025
Transcriptomic stratification predicts response to rituximab, abatacept, or the association of hydroxychloroquine and leflunomide in 3 randomised controlled clinical trials of Sjögren's diseaseBaptiste Chevet, Valérie Devauchelle-Pensec, Elena Pontarini, et al.
Rheumatology (Oxford, England)|March 2, 2024
Inclusion-body myositis associated with Sjögren's disease: clinical characteristics and comparison with other Sjögren-associated myositisQuentin Astouati, Thomas Machet, Camille Houssais, et al.
RMD Open|March 15, 2024
Concordance and agreement between different activity scores in polymyalgia rheumaticaJustine D'Agostino, Aghiles Souki, Anne Lohse, et al.
Rheumatology (Oxford, England)|May 10, 2015
Development of the Sjögren's Syndrome Responder Index, a data-driven composite endpoint for assessing treatment efficacyDivi Cornec, Valérie Devauchelle-Pensec, Xavier Mariette, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|October 25, 2022
Autoreactive Plasmablasts After B Cell Depletion With Rituximab and Relapses in Antineutrophil Cytoplasmic Antibody-Associated VasculitisAlvise Berti, Sophie Hillion, Maximilian F Konig, et al.
Seminars in Arthritis and Rheumatism|July 20, 2014
Association of mastocytosis with inflammatory joint diseases: a series of 31 patientsBrigitte Bader-Meunier, Cristina Bulai Livideanu, Claire Larroche, et al.
Plos One|September 15, 2015
Which and How Many Patients Should Be Included in Randomised Controlled Trials to Demonstrate the Efficacy of Biologics in Primary Sjögren's Syndrome?Valérie Devauchelle-Pensec, Jacques-Eric Gottenberg, Sandrine Jousse-Joulin, et al.
Rheumatology (Oxford, England)|January 18, 2018
Pharmacokinetics of rituximab and clinical outcomes in patients with anti-neutrophil cytoplasmic antibody associated vasculitisDivi Cornec, Brian F Kabat, John R Mills, et al.
Scientific Reports|March 19, 2021
Venous thrombosis and predictors of relapse in eosinophil-related diseasesValériane Réau, Alexandre Vallée, Benjamin Terrier, et al.
JCI Insight|October 7, 2021
Circulating autoreactive proteinase 3+ B cells and tolerance checkpoints in ANCA-associated vasculitisAlvise Berti, Sophie Hillion, Amber M Hummel, et al.
Pageof 20

Showing results (181-190 of 197) with videos related to

Sort By:
Pageof 20
Annals of the Rheumatic Diseases|December 25, 2025
Transcriptomic stratification predicts response to rituximab, abatacept, or the association of hydroxychloroquine and leflunomide in 3 randomised controlled clinical trials of Sjögren's diseaseBaptiste Chevet, Valérie Devauchelle-Pensec, Elena Pontarini, et al.
Rheumatology (Oxford, England)|March 2, 2024
Inclusion-body myositis associated with Sjögren's disease: clinical characteristics and comparison with other Sjögren-associated myositisQuentin Astouati, Thomas Machet, Camille Houssais, et al.
RMD Open|March 15, 2024
Concordance and agreement between different activity scores in polymyalgia rheumaticaJustine D'Agostino, Aghiles Souki, Anne Lohse, et al.
Rheumatology (Oxford, England)|May 10, 2015
Development of the Sjögren's Syndrome Responder Index, a data-driven composite endpoint for assessing treatment efficacyDivi Cornec, Valérie Devauchelle-Pensec, Xavier Mariette, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|October 25, 2022
Autoreactive Plasmablasts After B Cell Depletion With Rituximab and Relapses in Antineutrophil Cytoplasmic Antibody-Associated VasculitisAlvise Berti, Sophie Hillion, Maximilian F Konig, et al.
Seminars in Arthritis and Rheumatism|July 20, 2014
Association of mastocytosis with inflammatory joint diseases: a series of 31 patientsBrigitte Bader-Meunier, Cristina Bulai Livideanu, Claire Larroche, et al.
Plos One|September 15, 2015
Which and How Many Patients Should Be Included in Randomised Controlled Trials to Demonstrate the Efficacy of Biologics in Primary Sjögren's Syndrome?Valérie Devauchelle-Pensec, Jacques-Eric Gottenberg, Sandrine Jousse-Joulin, et al.
Rheumatology (Oxford, England)|January 18, 2018
Pharmacokinetics of rituximab and clinical outcomes in patients with anti-neutrophil cytoplasmic antibody associated vasculitisDivi Cornec, Brian F Kabat, John R Mills, et al.
Scientific Reports|March 19, 2021
Venous thrombosis and predictors of relapse in eosinophil-related diseasesValériane Réau, Alexandre Vallée, Benjamin Terrier, et al.
JCI Insight|October 7, 2021
Circulating autoreactive proteinase 3+ B cells and tolerance checkpoints in ANCA-associated vasculitisAlvise Berti, Sophie Hillion, Amber M Hummel, et al.
Pageof 20